Larson Financial Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.55K Buy
136
+27
+25% +$1.17K ﹤0.01% 2735
2026
Q2
$4.26K Buy
109
+65
+148% +$2K ﹤0.01% 2844
2026
Q1
$1.19K Buy
44
+39
+780% +$1.31K ﹤0.01% 3101
2025
Q4
$214 Buy
+5
New +$188 ﹤0.01% 3263

Other funds holding RIGL

Larson Financial Group's RIGL Position: Q3 2026 in Review

Larson Financial Group increased its Rigel Pharmaceuticals (RIGL) stake by 25% in Q3 2026, buying an estimated $1.17K and bringing the position to 136 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2735.

Larson Financial Group first reported a position in RIGL in Q4 2025 and has held it in 4 quarters since. 169 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • Larson Financial Group held 136 shares of Rigel Pharmaceuticals worth $6.55K as of Q3 2026.
  • Larson Financial Group bought 27 Rigel Pharmaceuticals shares in Q3 2026, an estimated $1.17K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2735 holding.
  • Larson Financial Group first reported a position in Rigel Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 169 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.